110|1676|Public
50|$|The enzyme {{reactant}} {{test strips}} react when the buffer solution breaks the <b>bacterial</b> <b>wall.</b> This breach releases enzymes, which react upon contact to the enzyme test strips.|$|E
5000|$|... #Caption: PBP are {{responsible}} for cross-linking in the bacterial cell wall. They make peptide bonds between lysine and alanine. Cephalosporins bind into the reaction site of PBP’s rendering the enzyme unable to cross-link the <b>bacterial</b> <b>wall</b> giving bactericidal activity.|$|E
50|$|Bambermycin is a {{performance}} enhancing antibiotic intended and available solely {{for use in}} animal nutrition. Its mechanism of action is to inhibit the synthesis of the <b>bacterial</b> <b>wall.</b> Bambermycin is predominately effective against Gram-positive pathogenic bacteria. However, {{it does not have}} significant action against Lactobacillus, Bifidobacterium, and other protective bacteria.|$|E
5000|$|... 1967 James Baddiley, Teichoic {{acids and}} the {{molecular}} structure of <b>bacterial</b> <b>walls</b> ...|$|R
2500|$|Around {{the outside}} of the cell {{membrane}} is the <b>bacterial</b> cell <b>wall.</b> <b>Bacterial</b> cell <b>walls</b> are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. <b>Bacterial</b> cell <b>walls</b> are different from the cell walls of plants and fungi which are made of cellulose and chitin, respectively. The cell wall of bacteria is also distinct from that of Archaea, which do not contain peptidoglycan. The cell wall is essential to the survival of many bacteria, although L-form bacteria can be produced in the laboratory that lack a cell wall. [...] The antibiotic penicillin is able to kill bacteria by preventing the cross-linking of peptidoglycan and this causes the cell wall to weaken and lyse. The lysozyme enzyme can also damage <b>bacterial</b> cell <b>walls.</b>|$|R
30|$|The {{interaction}} of Ag+ ions with the proteins containing sulfur {{present in the}} <b>bacterial</b> cell <b>wall</b> irreversibly caused the disruption of the <b>bacterial</b> cell <b>wall.</b> This proposed mechanism is also deduced as the main antibacterial mechanism in evaluating the antimicrobial activity.|$|R
50|$|Meropenem is {{bactericidal}} except against Listeria monocytogenes, {{where it}} is bacteriostatic. It inhibits <b>bacterial</b> <b>wall</b> synthesis like other β-lactam antibiotics. In contrast to other beta-lactams, it is highly resistant to degradation by β-lactamases or cephalosporinases. In general, resistance arises due to mutations in penicillin-binding proteins, production of metallo-β-lactamases, or resistance to diffusion across the bacterial outer membrane. Unlike imipenem, it is stable to dehydropeptidase-1, so can be given without cilastatin.|$|E
50|$|An {{inactivated vaccine}} {{consists}} of virus or bacteria that are grown in culture and then killed using a method such as heat or formaldehyde. Although the virus or bacteria particles are destroyed and cannot replicate, the virus capsid proteins or <b>bacterial</b> <b>wall</b> are intact {{enough to be}} recognized and remembered by {{the immune system and}} evoke a response. When manufactured correctly, the vaccine is not infectious, but improper inactivation can result in intact and infectious particles. Since the properly produced vaccine does not reproduce, booster shots are required periodically to reinforce the immune response.|$|E
5000|$|Glutamate {{racemase}} {{has emerged}} as a potential antibacterial target since the product of this enzyme, D-glutamate, is an essential component of bacterial walls. Inhibiting the enzyme will prevent <b>bacterial</b> <b>wall</b> formation and ultimately result in lysis of the bacteria cell by osmotic pressure. Furthermore, glutamate racemase is not expressed nor is the product of this enzyme, D-glutamate is normally found in mammals, hence inhibiting this enzyme should not result in toxicity to the mammalian host organism. [...] Possible inhibitors to MurI includes aziridino-glutamate that would alkylate the catalytic cysteines; N-hydroxy glutamate that by mimicking Wat2 (the bound water molecule that interacts with glutamate amino group) would prevent binding of the substrate; or 4-substituted D-glutamic acid analogs bearing aryl-, heteroaryl-, cinnamyl-, or biaryl-methyl substituents that would also prevent binding of substrate.|$|E
50|$|PBPs are all {{involved}} {{in the final stages}} of the synthesis of peptidoglycan, which is the major component of <b>bacterial</b> cell <b>walls.</b> <b>Bacterial</b> cell <b>wall</b> synthesis is essential to growth, cell division (thus reproduction) and maintaining the cellular structure in bacteria. Inhibition of PBPs leads to irregularities in cell wall structure such as elongation, lesions, loss of selective permeability, and eventual cell death and lysis.|$|R
40|$|Mutanolysin {{biosynthesis}} and pigment {{production in}} Streptomyces globisporus ATCC 21553 were stimulated by adding <b>bacterial</b> cell <b>walls</b> to the medium. The increased bacteriolytic {{activity in the}} supernatant correlated with an increased de novo synthesis of mutanolysin and was between 4 - and 20 -fold higher than in cultures grown without <b>bacterial</b> cell <b>walls.</b> The increase in mutanolysin synthesis was brought about by enhanced transcription of the mutanolysin gene. The stimulation was only observed in medium which contained dextrin or starch as the carbon source. Glucose abolished the stimulation and also inhibited the low constitutive synthesis of mutanolysin. The induction of lytic activity was observed to require minimally 0. 4 mg of <b>bacterial</b> cell <b>walls</b> per ml, whereas 0. 6 mg of <b>bacterial</b> cell <b>walls</b> per ml yielded maximal lytic activity. Further supplements of <b>bacterial</b> cell <b>walls</b> {{did not result in}} enhanced lytic activity. The stimulation could be achieved independently of the phase of growth of the Streptomyces strain. Cultures grown in the presence of <b>bacterial</b> cell <b>walls</b> exhibited a higher growth yield. However, the accelerated growth was not the reason for the increased amount of mutanolysin produced. The growth of cultures with peptidoglycan monomers added to the medium instead of cell walls was similarly increased, but an effect on the biosynthesis of mutanolysin was not observed. All <b>bacterial</b> cell <b>walls</b> tested were capable of eliciting the stimulation of lytic activity, including cell walls of archaea, which contained pseudomurein...|$|R
5000|$|Penicillin, which {{inhibits}} DD-transpeptidase {{from building}} <b>bacterial</b> cell <b>walls.</b>|$|R
5000|$|As a {{by-product}} of his work on type-specific staphylococcus antigens, Verwey reported in 1940 that a protein fraction prepared from extracts of these bacteria non-specifically precipitated rabbit antisera raised against different staphylococcus types. In 1958, Jensen confirmed Verwey’s finding and showed that rabbit pre-immunization sera as well as normal human sera bound to the active component in the staphylococcus extract; he designated this component Antigen A (because it was found in fraction A of the extract) but {{thought it was a}} polysaccharide. The misclassification of the protein was the result of faulty tests [...] but it was not long thereafter (1962) that Löfkvist and Sjöquist corrected the error and confirmed that Antigen A was in fact a surface protein on the <b>bacterial</b> <b>wall</b> of certain strains of S. aureus. The Bergen group from Norway named the protein [...] "Protein A" [...] after the antigen fraction isolated by Jensen.|$|E
50|$|Infection {{begins when}} G protein binds to lipopolysaccharides on the {{bacterial}} host cell surface. H protein (or the DNA Pilot Protein) pilots the viral genome through the bacterial membrane of E.coli bacteria (Jazwinski et al. 1975) most likely via a predicted N-terminal transmembrane domain helix (Tusnady and Simon, 2001). However, {{it has become}} apparent that H protein is a multifunctional protein (Cherwa, Young and Fane, 2011). This is the only viral capsid protein of ΦX174 to lack a crystal structure {{for a couple of}} reasons. It has low aromatic content and high glycine content, making the protein structure very flexible and in addition, individual hydrogen atoms (the R group for glycines) are difficult to detect in protein crystallography. Additionally, H protein induces lysis of the bacterial host at high concentrations as the predicted N-terminal transmembrane helix easily pokes holes through the <b>bacterial</b> <b>wall.</b> By bioinformatics, this protein contains four predicted coiled-coil domains which has a significant homology to known transcription factors. Additionally, it was determined by Ruboyianes et al. (2009) that de novo H protein was required for optimal synthesis of other viral proteins. Interestingly, mutations in H protein that prevent viral incorporation, can be overcome when excess amounts of Protein B, the internal scaffolding protein, are supplied.|$|E
40|$|INTRODUCTION: Vascular endothelial {{growth factor}} (VEGF) {{is a potent}} mitogenic {{cytokine}} which {{has been identified as}} the principal polypeptide growth factor influencing endothelial cell (EC) migration and proliferation. Ordered progression of these two processes is an absolute prerequisite for initiating and maintaining the proliferative phase of wound healing. The response of ECs to circulating VEGF is determined by, and directly proportional to, the functional expression of VEGF receptors (KDR/Flt- 1) on the EC surface membrane. Systemic sepsis and wound contamination due to bacterial infection are associated with significant retardation of the proliferative phase of wound repair. The effects of the Gram-negative <b>bacterial</b> <b>wall</b> components lipopolysaccharide (LPS) and bacterial lipoprotein (BLP) on VEGF receptor function and expression are unknown and may represent an important biological mechanism predisposing to delayed wound healing in the presence of localized or systemic sepsis. MATERIALS AND METHODS: We designed a series of in vitro experiments investigating this phenomenon and its potential implications for infective wound repair. VEGF receptor density on ECs in the presence of LPS and BLP was assessed using flow cytometry. These parameters were assessed in hypoxic conditions as well as in normoxia. The contribution of CD 14 was evaluated using recombinant human (rh) CD 14. EC proliferation in response to VEGF was quantified in the presence and absence of LPS and BLP. RESULTS: Flow cytometric analysis revealed that LPS and BLP have profoundly repressive effects on VEGF receptor density in normoxic and, more pertinently, hypoxic conditions. The observed downregulation of constitutive and inducible VEGF receptor expression on ECs was not due to any directly cytotoxic effect of LPS and BLP on ECs, as measured by cell viability and apoptosis assays. We identified a pivotal role for soluble/serum CD 14, a highly specific <b>bacterial</b> <b>wall</b> product receptor, in mediating these effects. The decreased VEGF receptor density on ECs accruing from the presence of <b>bacterial</b> <b>wall</b> products resulted in EC hyporesponsiveness to rhVEGF and significant abolition of VEGF-directed EC proliferation. CONCLUSION: These findings suggest that the well-recognized relationship between bacterial sepsis and attenuated wound healing may be due, in part, to the directly suppressive effects of <b>bacterial</b> <b>wall</b> components on EC VEGF receptor expression and, consequently, EC proliferation...|$|E
30|$|RIF-SLNs may better {{penetrate}} the <b>bacterial</b> cell <b>wall</b> {{due to their}} small size and hydrophobic nature {{which is similar to}} gram negative <b>bacterial</b> cell <b>wall.</b> Also, SLNs can effectively hinder the effect of P-gp pumps [21]. Moreover, this formulation possibly will be able to decrease the administration frequency due to prolonged drug release.|$|R
5000|$|Cefotaxime is a β-lactam {{antibiotic}} (which {{refers to}} the structural components of the drug molecule itself). As a class, β-lactams inhibit <b>bacterial</b> cell <b>wall</b> synthesis by binding {{to one or more}} of the penicillin-binding proteins (PBPs). This inhibits the final transpeptidation step of peptidoglycan synthesis in <b>bacterial</b> cell <b>walls,</b> thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) in the absence of cell wall assembly. [...] Due to the mechanism of their attack on <b>bacterial</b> cell <b>wall</b> synthesis, β-lactams are considered to be bactericidal.|$|R
5000|$|Preferential cleavage: Ala-, Val- in <b>bacterial</b> cell <b>walls,</b> elastin {{and other}} {{proteins}} ...|$|R
40|$|The {{mechanism}} {{of interaction between}} Mycobacterium leprae and neural cells has not been elucidated so far. No satisfactory interpretation exists as to the bacterium tropism to the peripheral nervous system in particular. The present study is {{a review of the}} micro-physiology of the extracellular apparatus attached to Schwann cells, {{as well as on the}} description of morphological units probably involved in the process of the binding to the <b>bacterial</b> <b>wall...</b>|$|E
40|$|Clindamycin {{treatment}} of Staphylococcus aureus caused a remarkable thickening of the {{bacterial cell wall}} and made the <b>bacterial</b> <b>wall</b> much more resistant against lytic enzymes within bone marrow-derived macrophages as revealed by electron microscopy and radiolabeling experiments. This reduced wall degradability resulted from an increased number of O-acetyl groups in the murein. Furthermore, such clindamycin-treated bacteria were ingested by adherent bone marrow-derived macrophages {{at a higher rate}} than untreated bacteria. The medical aspects of these results are discussed...|$|E
40|$|The mature {{forms of}} the {{extracellular}} muramidase- 2 of Enterococcus hirae and Streptococcus faecalis autolysin have very similar primary structures. Each consists of an active-site-containing N-terminal domain fused to a multiple-repeat C-terminal domain. Polypeptide segments occurring at equivalent places in these two <b>bacterial</b> <b>wall</b> lytic enzymes have homologues in two phage lysozymes and in three functionally unrelated proteins, illustrating the principle that protein molecules frequently are constructed from modules that are linked in a single polypeptide chain. Peer reviewe...|$|E
5000|$|... #Caption: Penicillin binding protein forming cross-links in {{newly formed}} <b>bacterial</b> cell <b>wall.</b>|$|R
5000|$|... #Caption: Transmission {{electron}} micrograph of multiple bacteriophages {{attached to a}} <b>bacterial</b> cell <b>wall</b> ...|$|R
5000|$|... {{possess a}} {{physiological}} role (e.g. components of <b>bacterial</b> cell <b>walls,</b> neurotransmitters and toxins), ...|$|R
30|$|Polymyxin-B hemoperfusion (PMX-HP) [1] is a blood {{purification}} technique designed to bind and neutralize circulating endotoxins by extracorporeal removal, inhibiting {{the progression of}} the septic cascade mediated by lipopolysaccharide (LPS) [2 – 16], the core lipid portion of the Gram negative <b>bacterial</b> <b>wall.</b> Endotoxin {{is removed from the}} blood by extracorporeal hemoperfusion with a polymyxin-B-adsorbing cartridge that binds endotoxin through covalent and ionic bonds. This therapy was first introduced in Japan in 1994 and 10  years later it was introduced in Europe.|$|E
40|$|Structural {{data are}} now {{available}} for comparing a penicillin target enzyme, the D-alanyl-D-alanine-peptidase from Streptomyces R 61, with a penicillin-hydrolyzing enzyme, the beta-lactamase from Bacillus licheniformis 749 /C. Although the two enzymes have distinct catalytic properties and lack relatedness in their overall amino acid sequences except near the active-site serine, the significant similarity found by x-ray crystallography in the spatial arrangement {{of the elements of}} secondary structure provides strong support for earlier hypotheses that beta-lactamases arose from penicillin-sensitive D-alanyl-D-alanine-peptidases involved in <b>bacterial</b> <b>wall</b> peptidoglycan metabolism. Peer reviewe...|$|E
40|$|Summary. R. Freter et al (1983) {{developed}} a simple chemostat-based model of competition between two bacterial strains, {{one of which}} is capable of wall-growth, in order to illuminate the role of <b>bacterial</b> <b>wall</b> attachment on the phenomenon of colonization resistance in the mammalian gut. Together with various collaborators, we have re-formulated the model in the setting of a tubular flow reactor, extended the interpretation of the model as a biofilm model, and provided both mathematical analysis and numerical simulations of solution behavior. The present paper provide...|$|E
50|$|As {{in other}} organisms, the <b>bacterial</b> cell <b>wall</b> {{provides}} structural integrity to the cell. In prokaryotes, the primary {{function of the}} cell wall {{is to protect the}} cell from internal turgor pressure caused by the much higher concentrations of proteins and other molecules inside the cell compared to its external environment. The <b>bacterial</b> cell <b>wall</b> differs from that of all other organisms by the presence of peptidoglycan (poly-N-acetylglucosamine and N-acetylmuramic acid), which is located immediately outside of the cytoplasmic membrane. Peptidoglycan is responsible for the rigidity of the <b>bacterial</b> cell <b>wall</b> and for the determination of cell shape. It is relatively porous and is not considered to be a permeability barrier for small substrates. While all <b>bacterial</b> cell <b>walls</b> (with a few exceptions e.g. intracellular parasites such as Mycoplasma) contain peptidoglycan, not all cell walls have the same overall structures. This is notably expressed through the classification into gram positive and gram negative bacteria.|$|R
5000|$|C55-isoprenyl pyrophosphate, a {{molecule}} which carries {{the building blocks}} of the peptidoglycan <b>bacterial</b> cell <b>wall</b> ...|$|R
50|$|This enzyme is {{involved}} in the biosynthesis of teichoic acid linkage units in <b>bacterial</b> cell <b>walls.</b>|$|R
40|$|A {{new model}} for the transpeptidation {{reaction}} involved in the biosynthesis of the <b>bacterial</b> <b>wall</b> peptidoglycan and for its inhibition by penicillin is proposed. This model is in open conflict with the hypotheses previously postulated. It rests upon the demonstration that 1) carboxypeptidase and transpep-tidase activities are performed by the same enzyme, 2) inhibition of both activities by penicillin is {{carried out in the}} absence of irreversible acylation of the protein, 3) the enzyme contains multiple sites some of which are involved in regulation, 4) penicillin does not act as a structural analogue of the donor peptide involved in transpeptidation but may act at the level of regulatory site(s) ...|$|E
40|$|NOD 2 {{plays an}} {{important}} role in the innate immunity of the intestinal tract. By sensing themuramyl dipeptide (MDP), a <b>bacterial</b> <b>wall</b> component, NOD 2 triggers the NF-B signal-ing pathway and promotes the release of proinflammatory cytokines such as interleukin- 8. Mutations in Nod 2 (1007 FS, R 702 W, G 908 R) impinge on NOD 2 functions and are associ-ated with the pathogenesis of Crohn disease, a chronic inflammatory bowel disease. Although NOD 2 is usually described as a cytosolic receptor for MDP, the protein is also localized at the plasma membrane, and the 1007 FS mutation delocalizes NOD 2 to the cytoplasm (Barnich, N., Aguirre...|$|E
40|$|ABSTRACT. The key {{component}} of the sepsis pathogenesis is the gram-negative bacteria endotoxin. It is a lipopolysaccharide of the <b>bacterial</b> <b>wall,</b> which circulation in the bloodstream results in unlimited activation of some biological systems, causing serious complications. Nowadays, there are developed and practiced sorption methods, based on the selective removal of the lipopolysaccharide from the blood during perfusion through the sorption column with covalently immobilized polymyxin on a bioinert matrix, which can bind and inactivate it. The therapeutic effect of hemosorption using the biospecific antilipopolysaccharide hemosorbent has been studied in patients with septic shock, associated with peritonitis and septic complications of destructive pancreatitis.  </p...|$|E
40|$|AbstractToll-like {{receptor}} (TLR) 2 and TLR 4 are {{implicated in}} the recognition of various <b>bacterial</b> cell <b>wall</b> components, such as lipopolysaccharide (LPS). To investigate in vivo roles of TLR 2, we generated TLR 2 -deficient mice. In contrast to LPS unresponsiveness in TLR 4 -deficient mice, TLR 2 -deficient mice responded to LPS {{to the same extent}} as wild-type mice. TLR 2 -deficient macrophages were hyporesponsive to several Gram-positive <b>bacterial</b> cell <b>walls</b> as well as Staphylococcus aureus peptidoglycan. TLR 4 -deficient macrophages lacked the response to Gram-positive lipoteichoic acids. These results demonstrate that TLR 2 and TLR 4 recognize different <b>bacterial</b> cell <b>wall</b> components in vivo and TLR 2 {{plays a major role in}} Gram-positive bacterial recognition...|$|R
50|$|This is a zinc enzyme. Catalyses carboxypeptidation but not transpeptidation {{reactions}} {{involved in}} <b>bacterial</b> cell <b>wall</b> metabolism.|$|R
2500|$|The cell {{envelope}} {{is composed}} of the plasma membrane and cell wall. As in other organisms, the <b>bacterial</b> cell <b>wall</b> provides structural integrity to the cell. In prokaryotes, the primary function of the cell wall {{is to protect the}} cell from internal turgor pressure caused by the much higher concentrations of proteins and other molecules inside the cell compared to its external environment. The <b>bacterial</b> cell <b>wall</b> differs from that of all other organisms by the presence of peptidoglycan which is located immediately outside of the cytoplasmic membrane. Peptidoglycan is made up of a polysaccharide backbone consisting of alternating N-Acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) residues in equal amounts. Peptidoglycan is responsible for the rigidity of the <b>bacterial</b> cell <b>wall</b> and for the determination of cell shape. It is relatively porous and is not considered to be a permeability barrier for small substrates. While all <b>bacterial</b> cell <b>walls</b> (with a few exceptions e.g. extracellular parasites such as Mycoplasma) contain peptidoglycan, not all cell walls have the same overall structures. Since the cell wall is required for bacterial survival, but is absent in some eukaryotes, several antibiotics (notably the penicillins and cephalosporins) stop bacterial infections by interfering with cell wall synthesis, while having no effects on human cells which have no cell wall only a cell membrane. There are two main types of <b>bacterial</b> cell <b>walls,</b> those of gram-positive bacteria and those of gram-negative bacteria, which are differentiated by their Gram staining characteristics. [...] For both these types of bacteria, particles of approximately 2nm can pass through the peptidoglycan. If the <b>bacterial</b> cell <b>wall</b> is entirely removed, it is called a protoplast while if it's partially removed, it is called a spheroplast. β-Lactam antibiotics such as penicillin inhibit the formation of peptidoglycan cross-links in the <b>bacterial</b> cell <b>wall.</b> The enzyme lysozyme, found in human tears, also digests the cell wall of bacteria and is the body's main defense against eye infections.|$|R
